Ticker: HZO

MarineMax

Consumer Consumer Cyclical Specialty Retail
Price 52.41
Reco Buy Potential 72 Risk 34 Updated 2026-09-24

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

MarineMax is a leading retailer of recreational boats and related products in the United States. The company specializes in the sale of new and used boats, including yachts, fishing boats, and personal watercraft. Its major business segments include retail sales, service, and parts. MarineMax generates revenue primarily through the sale of boats, as well as from service and maintenance, financing, and insurance products. The company operates a network of retail locations across the country, catering to a diverse customer base of boating enthusiasts.

Investment Profile

The investment profile of MarineMax is more aligned with growth investors, given its recent revenue increase and potential for expansion in the recreational boating market. The company may appeal to those seeking capital appreciation rather than income generation, as it does not currently offer dividends. Investors should consider the company's growth trajectory and market position when evaluating its suitability for their portfolios.

Fundamental metrics (experimental) Updated: 2026-09-20
EPS (TTM) — earnings per share for the last 12 months, $
0.18
Revenue QoQ — quarter-over-quarter revenue growth
15.9%
20d volatility
0.2%
AI recommendation changes
Date Before After Reason
2026-09-08 Sell Buy Strong momentum and revenue growth support bullish outlook.
2026-09-05 Buy Sell Weak momentum and uncertain fundamentals limit upside potential.
2026-08-11 — Buy Strong momentum and positive revenue growth signal opportunity.
Analyst forecasts
Date Analyst Action Target Price Then
2026-08-12 Truist Financial Rating Downgraded — → 53 52.46
2026-08-11 Loop Capital Markets Rating Downgraded — → 53 52.12
2026-07-24 Northcoast Research Target Raised 33 → 39 33.57
News Page 1 of 1